Pharmacy Times October 14, 2024
Key Takeaways
- AI enhances drug development by improving data utilization, reducing inefficiencies, and accelerating timelines through integration with wearable technologies, EHRs, and medical devices.
- AI aids regulatory processes by automating routine tasks, enhancing decision-making, and ensuring compliance, while human expertise remains crucial for interpreting results and ethical decisions.
- The pharmaceutical sector’s significant investment in AI highlights its transformative potential, though a shortage of skilled professionals persists, emphasizing the need for workforce development.
- AI’s role in precision medicine and regulatory operations promises more effective, personalized treatments, enriching clinical trials and accelerating drug discovery.
Artificial Intelligence (AI) refers to the capability of machines to perform tasks typically requiring human intelligence, such as reasoning, learning from experience, and problem-solving; the aim...
Today's Sponsors
Today's Sponsor